Literature DB >> 3930486

Structural characterization of proteoglycans produced by testicular peritubular cells and Sertoli cells.

M K Skinner, I B Fritz.   

Abstract

The structural characteristics of proteoglycans produced by seminiferous peritubular cells and by Sertoli cells are defined. Peritubular cells secrete two proteoglycans designated PC I and PC II. PC I is a high molecular mass protein containing chondroitin glycosaminoglycan (GAG) chains (maximum 70 kDa). PC II has a protein core of 45 kDa and also contains chondroitin GAG chains (maximum 70 kDa). Preliminary results imply that PC II may be a degraded or processed form of PC I. A cellular proteoglycan associated with the peritubular cells is described which has properties similar to those of PC I. Sertoli cells secrete two different proteoglycans, designated SC I and SC II. SC I is a large protein containing both chondroitin (maximum 62 kDa) and heparin (maximum 15 kDa) GAG chains. Results obtained suggest that this novel proteoglycan contains both chondroitin and heparin GAG chains bound to the same core protein. SC II has a 50-kDa protein core and contains chondroitin (maximum 25 kDa) GAG chains. A proteoglycan obtained from extracts of Sertoli cells is described which contains heparin (maximum 48 kDa) GAG chains. In addition, Sertoli cells secrete a sulfoprotein, SC III, which is not a proteoglycan. SC III has properties similar to those of a major Sertoli cell-secreted protein previously defined as a dimeric acidic glycoprotein. The stimulation by follicle-stimulating hormone of the incorporation of [35S]SO2(-4) into moieties secreted by Sertoli cells is shown to represent an increased production or sulfation of SC III (i.e. dimeric acidic glycoprotein), and not an increased production or sulfation of proteoglycans. Results are discussed in relation to the possible functions of proteoglycans in the seminiferous tubule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930486

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Characterization of a human seminal plasma glycosaminoglycan-bearing polypeptide.

Authors:  F Bonnet; J P Perin; P Maillet; P Jolles; P M Alliel
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Lamina propria of sex cords in human fetal testis: an immunohistological and stereological study.

Authors:  D Jezek; A Hittmair; H Rogatsch; M Kos
Journal:  Anat Embryol (Berl)       Date:  1996-02

3.  Regulation of spermatogenesis by a local functional axis in the testis: role of the basement membrane-derived noncollagenous 1 domain peptide.

Authors:  Haiqi Chen; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  FASEB J       Date:  2017-05-09       Impact factor: 5.191

4.  Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia.

Authors:  R D Sanderson; M Bernfield
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Viability of meiotic prophase spermatocytes of rats is facilitated in primary culture of dispersed testicular cells on collagen gel by supplementing epinephrine or norepinephrine: evidence that meiotic prophase spermatocytes complete meiotic divisions in vitro.

Authors:  Y Nagao
Journal:  In Vitro Cell Dev Biol       Date:  1989-12

6.  Membrane associated proteoglycans in rat testicular peritubular cells.

Authors:  L Bichoualne; B Thiébot; M Langris; P Barbey; H Oulhaj; J Bocquet
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

7.  Experimental syphilitic orchitis. Relationship between Treponema pallidum infection and testis synthesis of proteoglycans.

Authors:  R A Strugnell; T Kent; C J Handley; S Faine
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

Review 8.  Building the mammalian testis: origins, differentiation, and assembly of the component cell populations.

Authors:  Terje Svingen; Peter Koopman
Journal:  Genes Dev       Date:  2013-11-15       Impact factor: 11.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.